Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Acute Myocardial Infarction
29%
Adverse Drug Reaction
11%
AIMS™
10%
All-cause Mortality
21%
Aneurysm Size
11%
Angiotensin-converting Enzyme Inhibitor (ACEi)
16%
Aortic Root
10%
Aortopathy
15%
Atrial Fibrillation
29%
Atrial Natriuretic Factor
15%
Beta-blockers
16%
Bicuspid Aortic Valve
13%
Brain Natriuretic Peptide
18%
Chronic Heart Failure
36%
Congestive Heart Failure
14%
Coronary Artery Disease
11%
Degradation Products
11%
Desmosine
61%
Elastin
37%
Elastin Degradation
28%
Endothelial Function
14%
Heart Failure
35%
Heart Failure Patients
13%
Heart Failure with Preserved Ejection Fraction (HFpEF)
10%
Heart Rate
11%
Hemoglobin A1c (HbA1c)
11%
Insulin Resistance
28%
Left Ventricular Dysfunction
11%
Left Ventricular Hypertrophy
16%
Left Ventricular Remodeling
11%
Loop Diuretics
13%
Marfan Syndrome
20%
Metformin
26%
Myocardial Infarction
12%
Natriuretic Peptides
11%
Non-diabetic
12%
Outcome Prediction
20%
Pathophysiology
13%
Patients with Coronary Artery Disease
16%
Patients with Heart Failure
40%
Placebo
21%
Plasma Parameters
20%
QT Prolongation
10%
Right Ventricular Pacing
12%
Ruptured Abdominal Aortic Aneurysm (rAAA)
15%
Scotland
15%
Sinus Rhythm
14%
Tayside
18%
Type 2 Diabetes Mellitus (T2DM)
22%
Type 2 Diabetic Patients
13%
Pharmacology, Toxicology and Pharmaceutical Science
Abdominal Aortic Aneurysm
15%
Acute Heart Infarction
29%
Adverse Drug Reaction
10%
Adverse Outcome
8%
All Cause Mortality
17%
Amiodarone
10%
Aneurysm
10%
Angiotensin
22%
Aortic Stenosis
10%
Atherosclerosis
9%
Atrial Fibrillation
29%
Atrial Natriuretic Factor
13%
Biological Marker
31%
Brain Natriuretic Peptide
19%
Cardiovascular Disease
9%
Carvedilol
7%
Cerebrovascular Accident
7%
Cohort Study
15%
Congestive Heart Failure
100%
Coronary Artery Disease
15%
Creatinine
7%
Dapagliflozin
9%
Desmosine
39%
Diabetes Mellitus
20%
Dipeptidyl Carboxypeptidase Inhibitor
15%
Diseases
9%
Elastin
27%
Endothelial Dysfunction
11%
Heart Arrhythmia
10%
Heart Failure with Reduced Ejection Fraction
10%
Heart Infarction
12%
Heart Left Ventricle Failure
11%
Heart Left Ventricle Hypertrophy
12%
Heart Ventricle Remodeling
11%
Insulin Resistance
26%
Left Ventricular Systolic Dysfunction
9%
Loop Diuretic Agent
12%
Metformin
21%
Natriuretic Factor
10%
Non Insulin Dependent Diabetes Mellitus
16%
Placebo
25%
Prazosin
9%
Prevalence
7%
Pulmonary Hypertension
9%
QT Prolongation
9%
Randomized Controlled Trial
10%
Renin
23%
Statin (Protein)
10%
Syndrome X
9%
Warfarin
8%
Medicine and Dentistry
Abdominal Aortic Aneurysm
14%
Acute Heart Infarction
14%
Adipose Tissue
5%
Adverse Outcome
7%
Aneurysm
10%
Aortic Stenosis
5%
Aortopathy
9%
Apoplexy
6%
Atherosclerosis
7%
Atrial Fibrillation
14%
Atrial Natriuretic Factor
15%
Beta Adrenergic Receptor Blocking Agent
5%
Biological Marker
36%
Blood Pressure
6%
Brain Natriuretic Peptide
19%
Cardiac Magnetic Resonance Imaging
6%
Cardiovascular Disease
11%
Cardiovascular Effect
9%
Cardiovascular System
14%
Congestive Heart Failure
47%
Coronary Artery Disease
20%
Cross Sectional Study
5%
Desmosine
29%
Diabetes
16%
Diabetes Mellitus
9%
Diseases
7%
Echocardiography
6%
Elastin
17%
Endothelial Dysfunction
8%
Endothelial Function
12%
Glycon
21%
Health Care Cost
5%
Heart Left Ventricle Failure
6%
Heart Muscle Perfusion
7%
Heart Output
11%
Insulin Resistance
24%
Left Ventricular Hypertrophy
15%
Loop Diuretic Agent
6%
Maturity Onset Diabetes of the Young
8%
Myocardial Infarction
5%
Natriuretic Factor
6%
Nitric Acid Derivative
5%
Pathophysiology
12%
Patient with Type 2 Diabetes
5%
Placebo
7%
Prevalence
6%
Randomized Controlled Trial
5%
Renin Angiotensin Aldosterone System
12%
Vasomotor
9%
Ventricle of Heart
7%
